AvantGuard is a finalist in the RESI Boston Innovator's Pitch Challenge
Join us Wednesday, September 25, at the Westin Copley Place, where our CEO, Ted Eveleth, will showcase our groundbreaking work. The RESI...
top of page
AvantGuard News
Search
Aug 9
​​​​AvantGuard Named Semi-Finalist in 2024 Pepperdine Most Fundable Companies Competition
We are thrilled to announce that AvantGuard has been named a Semi-Finalist in the 2024 Pepperdine Most Fundable Companies competition!...
Aug 1
Dr. Carine Nkemngong's Insights on Biofilms and Pathogen Persistence in Healthcare and Food Processing
Join us in celebrating Dr. Carine Nkemngong's latest paper, co-authored with Peter Teska from Diversey, on the critical role of biofilms...
Jul 11
The Source Code Podcast Features AvantGuard
We’re thrilled to announce that Ted Eveleth and Michael Newell recently joined Nishith (Nish) Acharya on Equal Innovation’s podcast, The...
May 24
AvantGuard at the Forefront of Wound Care and Medical Technology
AvantGuard's CEO attended three key medical conferences in May, showcasing commitment to advancing wound care and medical technologies.
Dec 12, 2023
AvantGuard Selected as Hello Tomorrow Deep Tech Pioneer: Shaping the Future of Pathogen Defense
AvantGuard is thrilled to share we have been chosen as one of the prestigious Hello Tomorrow Deep Tech Pioneers! This recognition is a...
Nov 8, 2023
AvantGuard Leads Charge at NewYorkBIO's Mini Pitch Day
We are thrilled to share that our CEO, Ted Eveleth, will be taking the stage at NewYorkBIO's Mini Pitch Day event on November 16th from...
Nov 2, 2023
Ted Eveleth, Shares AvantGuard’s Success Story at the 2023 New York State Innovation Summit
AvantGuard, a leading pioneer in antimicrobial solutions, was thrilled to have our CEO, Ted Eveleth, participate in the New York State...
Nov 2, 2023
AvantGuard Recognized as Top Key Player in the Surface Disinfectants Market by IMIR Market Research
We are thrilled to announce that AvantGuard has been recognized as a key player in the global Surface Disinfectants market by IMIR Market...
Oct 4, 2023
AvantGuard’s Bright Pitch Shines at TechCrunch Disrupt 2023
In the bustling landscape of innovation, AvantGuard emerged as a beacon of groundbreaking technology at this year's TechCrunch Disrupt...
Sep 25, 2023
AvantGuard Wants To Turn Chlorine Into the Best Antiseptic You’ve Ever Seen
AvantGuard's journey at TechCrunch Disrupt 2023 was nothing short of amazing! Ted Eveleth, AvantGuard's CEO, showcased the groundbreaking...
Sep 25, 2023
Device Strategies To Prevent Healthcare-Associated Infections
Nosocomial infections, commonly know as healthcare associated infections (HAIs) strike 1 in 31 hospital patients daily, but we can fight...
Sep 15, 2023
AvantGuard, Inc. Set to Make Waves at TechCrunch Disrupt 2023
We are excited to announce that AvantGuard has been handpicked to exhibit at TechCrunch Disrupt 2023, earning a coveted spot in the...
Jul 25, 2023
The Problem With Modern Disinfectants & What The Future of Infection Protection Should Look Like
Discover the drawbacks of current disinfectants and the exciting innovations poised to revolutionize how we safeguard against harmful...
Jun 7, 2023
$325K NIH Phase I Grant: Advancing Urinary Catheter Technology with AvantGuard
AvantGuard has been awarded a $325K NIH Phase I Grant for non-coating antimicrobial, anti-host deposition, anti-inflammatory urinary...
bottom of page